A new era of morality in business; pharmaceutical industry giants joining forces with prominent charities

The pharmaceutical industry has been weathering public controversies for decades, not only in dealing with damage control on countless patents that are either proven to be ineffective or dangerous, but also with the crushing cost of their drugs in developing countries. This last point has been painfully obvious with anti-malarial agents and HIV treatment; both are usually priced far beyond the means of those that most desperately need them.

Now things are beginning to look better. The BBC recently reported that Britain’s drug giant, GlaxoSmithKline, is radically changing tack and joining the much-needed philanthropic drive to save the lives of millions in Africa by joining forces with prominent charities like Save the Children. Read the rest of this entry →